[1]
Kokanov, N.S., Jovanović-Ćupić, S.P., Šiljić, M.M., Ćirković, V.S., Petrović, N.M., Kožik, B.R. and Krajnović, M.M. 2023. Variability of the HCV core region and host genetic and epigenetic factors can predict the response to pegylated interferon/ribavirin therapy in genotype 1b hepatitis C patients from Serbia. Archives of Biological Sciences. 75, 3 (Oct. 2023), 251–262. DOI:https://doi.org/10.2298/ABS230316020K.